{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:30:43Z","timestamp":1775615443361,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007760","name":"The Ohio State University College of Medicine Office of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121709"],"award-info":[{"award-number":["R01DK121709"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urology.2025.12.008","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:04:38Z","timestamp":1766163878000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Laboratory Abnormalities Associated With the Use of Preventive Pharmacological Therapy for Urinary Stone Disease"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-5821","authenticated-orcid":false,"given":"Matthew S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul Garcia","family":"Maya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn","family":"Valicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Oerline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeevkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan S.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahakn B.","family":"Shahinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.12.008_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JU.0000000000002331","article-title":"Incidence of kidney stones in the United States: the continuous national health and nutrition examination survey","volume":"207","author":"Hill","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.12.008_bib2","first-page":"220","article-title":"Incidence of upper urinary tract stones","volume":"13","author":"Ljunghall","year":"1987","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.urology.2025.12.008_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5287","article-title":"Kidney stones and kidney function loss: a cohort study","volume":"345","author":"Alexander","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.urology.2025.12.008_bib4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1089\/end.2016.0074","article-title":"Preliminary evidence of decreased disease-specific health-related quality of life in asymptomatic stone patients","volume":"30","author":"Penniston","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.urology.2025.12.008_bib5","unstructured":"Litwin MSSC. ed. Urologic Diseases in America. vol NIH Publication No. 12-7865. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Government Printing Office; 2012."},{"key":"10.1016\/j.urology.2025.12.008_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-5347(17)42599-7","article-title":"Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not","volume":"139","author":"Ettinger","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.12.008_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2025.12.008_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/UPJ.0000000000000480","article-title":"Understanding the barriers to preventive pharmacological therapy use in older patients with urinary stone disease","volume":"11","author":"Krampe","year":"2024","journal-title":"Urol Pract"},{"key":"10.1016\/j.urology.2025.12.008_bib9","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0022-5347(05)65505-X","article-title":"Patient adherence to long-term medical treatment of kidney stones","volume":"166","author":"Parks","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.12.008_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/UPJ.0000000000000470","article-title":"Comparison of class-specific side effects across preventative pharmacologic therapies for kidney stone disease","volume":"11","author":"Hsi","year":"2024","journal-title":"Urol Pract"},{"key":"10.1016\/j.urology.2025.12.008_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urology.2016.03.030","article-title":"Factors associated with preventive pharmacological therapy adherence among patients with kidney stones","volume":"93","author":"Dauw","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.12.008_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urology.2021.12.037","article-title":"Comparison of selective vs empiric pharmacologic preventive therapy of kidney stone recurrence with high-risk features","volume":"164","author":"Hsi","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.12.008_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.28953","article-title":"Thiazide dose, urine calcium, and symptomatic kidney stone events","volume":"7","author":"Hsi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urology.2025.12.008_bib14","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.urology.2025.12.008_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.ackd.2018.05.007","article-title":"Incomplete distal renal tubular acidosis and kidney stones","volume":"25","author":"Fuster","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.urology.2025.12.008_bib16","first-page":"162","article-title":"Clinical course of patients with bartter syndrome","volume":"16","author":"Rodriges","year":"2022","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.urology.2025.12.008_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1984.tb02488.x","article-title":"Thiazide-induced hypokalaemia; prevalence higher in women","volume":"18","author":"Toner","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.urology.2025.12.008_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2017.01.044","article-title":"Race, serum potassium, and associations with ESRD and mortality","volume":"70","author":"Chen","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.urology.2025.12.008_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/HYPERTENSIONAHA.108.120923","article-title":"Mechanistic insights into diuretic-induced insulin resistance","volume":"52","author":"Dronavalli","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.urology.2025.12.008_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/HYPERTENSIONAHA.108.114389","article-title":"Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute","volume":"52","author":"Carter","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.urology.2025.12.008_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"Savage","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2025.12.008_bib22","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.5489\/cuaj.8685","article-title":"Allopurinol hypersensitivity syndrome Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients","volume":"18","author":"Alotaibi","year":"2024","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urology.2025.12.008_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJM197011262832201","article-title":"Depletion of erythrocyte phosphoribosylpyrophosphate in man","volume":"283","author":"Fox","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2025.12.008_bib24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0140-6736(77)92683-6","article-title":"Allopurinol and agranulocytosis","volume":"2","author":"Wilkinson","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2025.12.008_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.12659\/AJCR.914166","article-title":"Pancytopenia and septic infection caused by concurrent use of allopurinol and mercaptopurine: a case report illustrating the importance of clinical pharmacist consultation","volume":"20","author":"Alhubaishi","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.urology.2025.12.008_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525013585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525013585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:32:29Z","timestamp":1775583149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525013585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S0090429525013585"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.12.008","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory Abnormalities Associated With the Use of Preventive Pharmacological Therapy for Urinary Stone Disease","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}